Average Co-Inventor Count = 8.70
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Constellation Pharmaceuticals, Inc. (25 from 54 patents)
2. C4 Therapeutics, Inc. (21 from 32 patents)
3. Genentech, Inc. (10 from 3,223 patents)
4. Bayer Aktiengesellschaft (8 from 12,164 patents)
5. The Broad Institute, Inc. (8 from 444 patents)
6. Bayer Pharma Aktiengesellschaft (8 from 378 patents)
7. University of Colorado (2 from 1,384 patents)
8. Other (1 from 832,880 patents)
9. Genetech, Inc. (1 from 98 patents)
10. C4 Therepeutics, Inc. (1 from 1 patent)
58 patents:
1. 12486290 - Isoindolinone and indazole compounds for the degradation of EGFR
2. 12486253 - Therapeutics for the degradation of mutant BRAF
3. 12454521 - Targeted protein degradation
4. 12441740 - N/O-linked degrons and degronimers for protein degradation
5. 12421220 - Bicyclic-substituted glutarimide cereblon binders
6. 12371442 - Isoindolinone and indazole compounds for the degradation of EGFR
7. 12227504 - Spirocyclic compounds
8. 12180225 - N/O-linked degrons and degronimers for protein degradation
9. 12157735 - Compounds for targeted degradation of BRD9
10. 12152041 - Macrocyclic fluorine substituted indole derivatives
11. 12076405 - Heterocyclic degronimers for target protein degradation
12. 12049464 - Compounds for targeted degradation of BRD9
13. 12048748 - Spirocyclic degronimers for target protein degradation
14. 12048747 - Substituted piperidine Degronimers for Target Protein degradation
15. 11992531 - C-carbon linked glutarimide degronimers for target protein degradation